Silk Road Medical, Inc
SILK
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 191.43M | 185.49M | 177.13M | 169.94M | 162.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 191.43M | 185.49M | 177.13M | 169.94M | 162.87M |
| Cost of Revenue | 49.24M | 49.51M | 50.05M | 48.56M | 45.82M |
| Gross Profit | 142.19M | 135.98M | 127.09M | 121.38M | 117.06M |
| SG&A Expenses | 159.71M | 151.72M | 145.03M | 138.44M | 131.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 251.60M | 242.78M | 236.40M | 227.46M | 215.96M |
| Operating Income | -60.17M | -57.29M | -59.27M | -57.53M | -53.08M |
| Income Before Tax | -56.50M | -53.38M | -55.70M | -55.32M | -52.85M |
| Income Tax Expenses | 43.00K | 43.00K | 43.00K | 29.00K | 29.00K |
| Earnings from Continuing Operations | -56.54 | -53.42 | -55.74 | -55.35 | -52.88 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -56.54M | -53.42M | -55.74M | -55.35M | -52.88M |
| EBIT | -60.17M | -57.29M | -59.27M | -57.53M | -53.08M |
| EBITDA | -57.55M | -54.65M | -56.57M | -54.83M | -50.49M |
| EPS Basic | -1.44 | -1.37 | -1.44 | -1.44 | -1.40 |
| Normalized Basic EPS | -0.90 | -0.86 | -0.90 | -0.90 | -0.88 |
| EPS Diluted | -1.44 | -1.37 | -1.44 | -1.44 | -1.40 |
| Normalized Diluted EPS | -0.90 | -0.86 | -0.90 | -0.90 | -0.88 |
| Average Basic Shares Outstanding | 156.80M | 155.94M | 155.21M | 153.77M | 150.21M |
| Average Diluted Shares Outstanding | 156.80M | 155.94M | 155.21M | 153.77M | 150.21M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
